| For: | Dimberg J, Shamoun L, Landerholm K, Wågsäter D. Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer. World J Gastroenterol 2022; 28(19): 2148-2151 [PMID: 35664033 DOI: 10.3748/wjg.v28.i19.2148] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i19/2148.htm |
| Number | Citing Articles |
| 1 |
І.А. Нromakova, P.P. Sorochan, N.E. Prokhach, І.S. Hromakova, D.V. Olkhovskyi . Metformin in the prevention and treatment of colorectal cancer . Український радіологічний та онкологічний журнал 2025; 33(1): 82 doi: 10.46879/ukroj.1.2025.82-99
|
| 2 |
Shuzhen Wu, Luyao Yu, Meitong Liu, Bo Dong. The intersection of colorectal cancer and cardiovascular disease: shared mechanisms and clinical implications. Clinical and Translational Oncology 2026; doi: 10.1007/s12094-026-04367-9
|
| 3 |
Barbora Salovska, Erli Gao, Sophia Müller‐Dott, Wenxue Li, Carlos Chacon Cordon, Shisheng Wang, Aurelien Dugourd, George Rosenberger, Julio Saez‐Rodriguez, Yansheng Liu. Phosphoproteomic analysis of metformin signaling in colorectal cancer cells elucidates mechanism of action and potential therapeutic opportunities. Clinical and Translational Medicine 2023; 13(2) doi: 10.1002/ctm2.1179
|